BioMarin Pharmaceutical (BMRN) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Speaker0 Good day, everyone, and welcome to the BioMarin Pharmaceutical First Quarter twenty twenty five Conference Call. Just a reminder that this conference is being recorded. I would now like to hand things over to Ms. Tracy McCarty. Please go ahead, ma'am. Speaker1 Thank you, operator. To remind you, this non confidential presentation contains forward looking statements about the business prospects of BioMarin Pharmaceutical I ...

BioMarin Pharmaceutical (BMRN) Q1 2025 Earnings Call May 01, 2025 04:30 PM ET Company Participants Traci McCarty - Group Vice President of Investor RelationsAlexander Hardy - President and Chief Executive OfficerBrian Mueller - CFO & EVPCristin Hubbard - Executive VP & Chief Commercial OfficerGreg Friberg - Executive Vice President, Chief Research & Development OfficerPhilip Nadeau - MD, Health Care – BiotechnologyTommie Reerink - Biotech Equity Research AssociateJenny Gonzalez-Armenta - Equity Research Ass ...

First Quarter 2025 Earnings May 1, 2025 Table of Contents 2 ● Business and Financial Highlights ● First Quarter 2025 Key Financial Metrics ● 2025 Guidance ● BMN 351 Model ● Non-GAAP Reconciliations Forward-Looking Statements This non-confidential presentation and the associated conference call and webcast contain forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc. (BioMarin), including, without limitation, statements about: future financial performance, including the expe ...